


MicrocynVS Revenue
Veterinary Services • Petaluma, California, United States • 1-10 Employees
MicrocynVS revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Veterinary Services industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at MicrocynVS
Benjamin Mcfadden
Director of Social Media
Company overview
| Headquarters | 1129 N McDowell Blvd, Petaluma, California 94954, US |
| Website | |
| SIC | 283 |
| Founded | 2018 |
| Employees | 1-10 |
About MicrocynVS
About MicrocynVS® The MicrocynVS® family of animal healthcare products are the ONLY animal healthcare products with the original Microcyn® Technology formulated exclusively for North American veterinarians. With over ten million creatures successfully treated with Microcyn® Technology—both four-legged and two—there has never been a single report of a serious adverse effect. It is a superior hypochlorous acid solution that is clinically proven safe, non-toxic and effective. Can safely be used around the nose, eyes, ears and mouth and requires no mixing or dilution. About Sonoma Pharmaceuticals, Inc. Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company’s headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
MicrocynVS has never raised funding before.
Frequently asked questions
4.8
40,000 users



